NUROI PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (NUROI PHARMACEUTICALS) WILL HOLD ITS ANNUAL GENERAL MEETING ON 18 JUNE 2024 AT WHICH GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES WILL BE PROPOSED, AS WELL AS A PROPOSAL TO RE-ELECT RETIRING DIRECTORS. THE GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES PREVIOUSLY GRANTED BY THE COMPANY'S SHAREHOLDERS AT THE ANNUAL GENERAL MEETING ON JUNE 15, 2023 WILL EXPIRE AT THE CLOSE OF THIS MEETING. In order to maintain the company's flexibility, it is proposed to grant the directors a new general mandate allowing the issuance of no more than 20% of the total issued shares and the repurchase of no more than 10% of the shares. In addition, Ms. WANG Qiu Qin, Mr. Yue Ping and...Show More

NUROI PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (NUROI PHARMACEUTICALS) WILL HOLD ITS ANNUAL GENERAL MEETING ON 18 JUNE 2024 AT WHICH GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES WILL BE PROPOSED, AS WELL AS A PROPOSAL TO RE-ELECT RETIRING DIRECTORS. THE GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES PREVIOUSLY GRANTED BY THE COMPANY'S SHAREHOLDERS AT THE ANNUAL GENERAL MEETING ON JUNE 15, 2023 WILL EXPIRE AT THE CLOSE OF THIS MEETING. In order to maintain the company's flexibility, it is proposed to grant the directors a new general mandate allowing the issuance of no more than 20% of the total issued shares and the repurchase of no more than 10% of the shares. In addition, Ms. WANG Qiu Qin, Mr. Yue Ping and Mr. Leung Chi Kin will retire and be eligible for re-election. THE NOTICE OF THE ANNUAL GENERAL MEETING HAS BEEN PUBLISHED ON THE COMPANY'S WEBSITE AND THE EXCHANGE WEBSITE AND REMINDS SHAREHOLDERS TO SUBMIT THE PROXY FORM ON OR BEFORE 16 JUNE 2024. The Company will also suspend the registration of shares from 13 June to 18 June 2024.